{"id":"parenteral-chemotherapy","safety":{"commonSideEffects":[{"rate":"10-30%","effect":"Neutropenia"},{"rate":"10-20%","effect":"Anemia"},{"rate":"5-15%","effect":"Thrombocytopenia"}]},"_chembl":{"chemblId":"CHEMBL4297950","moleculeType":"Protein"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Parenteral chemotherapy agents like this one work by interfering with the cell cycle, preventing cancer cells from dividing and growing. This leads to the induction of apoptosis, or programmed cell death, in cancer cells.","oneSentence":"This drug targets cancer cells by inhibiting cell division and inducing apoptosis.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:25:36.398Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Treatment of various cancers"}]},"trialDetails":[{"nctId":"NCT04930237","phase":"","title":"RELISTOR's Effects on Opioid-Induced Constipation","status":"WITHDRAWN","sponsor":"Methodist Health System","startDate":"2021-07-01","conditions":"OIC","enrollment":""},{"nctId":"NCT04992572","phase":"EARLY_PHASE1","title":"Study Comparing Local/ MAC Anesthesia in Lumbar Decompression","status":"RECRUITING","sponsor":"Stanford University","startDate":"2021-12-01","conditions":"Lumbar Spinal Stenosis","enrollment":100},{"nctId":"NCT05312970","phase":"PHASE4","title":"Varithena Versus Endothermal Ablation of the Great Saphenous Vein (VERITAS)","status":"TERMINATED","sponsor":"Boston Scientific Corporation","startDate":"2023-02-10","conditions":"Varicose Veins","enrollment":43},{"nctId":"NCT07319832","phase":"","title":"A Study of Teduglutide in Chinese Children and Teenagers With Short Bowel Syndrome","status":"RECRUITING","sponsor":"Takeda","startDate":"2026-03-05","conditions":"Short Bowel Syndrome (SBS)","enrollment":12},{"nctId":"NCT04829136","phase":"NA","title":"Sustained Oral Fiber Supplementation for Patients Undergoing Donor Stem Cell Transplantation for Hematological Malignancies","status":"RECRUITING","sponsor":"Fred Hutchinson Cancer Center","startDate":"2022-06-22","conditions":"Hematopoietic and Lymphatic System Neoplasm","enrollment":30},{"nctId":"NCT04083235","phase":"PHASE3","title":"A Study to Assess the Effectiveness and Safety of Irinotecan Liposome Injection, 5-fluorouracil/Leucovorin Plus Oxaliplatin in Patients Not Previously Treated for Metastatic Pancreatic Cancer, Compared to Nab-paclitaxel+Gemcitabine Treatment","status":"COMPLETED","sponsor":"Ipsen","startDate":"2020-02-11","conditions":"Metastatic Adenocarcinoma of the Pancreas","enrollment":770},{"nctId":"NCT05734625","phase":"PHASE2","title":"Efficacy of Nerve Blocks for Episodic Migraine","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2023-07-10","conditions":"Episodic Migraine","enrollment":60},{"nctId":"NCT07354464","phase":"PHASE3","title":"Efficacy of Sphenopalatine Block Compared to Blood Patch in the Management of Post-dural Puncture Headaches","status":"RECRUITING","sponsor":"University Hospital, Clermont-Ferrand","startDate":"2026-02-19","conditions":"PDPH, Post Dural Puncture Headache","enrollment":80},{"nctId":"NCT05398679","phase":"PHASE4","title":"Oral Antimicrobial Treatment vs. Outpatient Parenteral for Infective Endocarditis","status":"RECRUITING","sponsor":"Fundacion Clinic per a la Recerca Biomédica","startDate":"2022-08-17","conditions":"Endocarditis Infective","enrollment":360},{"nctId":"NCT07108114","phase":"PHASE1","title":"SLV-324 Treatment of Metastatic Solid Tumors","status":"RECRUITING","sponsor":"Solve Therapeutics","startDate":"2025-08-25","conditions":"Metastatic Solid Tumors","enrollment":70},{"nctId":"NCT03811821","phase":"NA","title":"Fecal Incontinence Treatment (FIT) Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"Mayo Clinic","startDate":"2019-02-01","conditions":"Fecal Incontinence, Bowel Incontinence","enrollment":275},{"nctId":"NCT04718168","phase":"NA","title":"GORE® ENFORM Biomaterial Product Study","status":"RECRUITING","sponsor":"W.L.Gore & Associates","startDate":"2021-05-17","conditions":"Hernia, Ventral, Hernia, Hiatal, Hernia, Diaphragmatic","enrollment":245},{"nctId":"NCT07413055","phase":"PHASE3","title":"Dexamethasone (4 mg vs. 8 mg) for Pain Control in Dental Implant Surgery","status":"RECRUITING","sponsor":"Oman Ministry of Health","startDate":"2026-02-05","conditions":"Postoperative Pain","enrollment":138},{"nctId":"NCT07414706","phase":"PHASE3","title":"Intravenous Lidocaine Plus Port-Site Ropivacaine for Recovery After Laparoscopic Surgery","status":"NOT_YET_RECRUITING","sponsor":"Centre Hospitalier Universitaire, Amiens","startDate":"2026-03","conditions":"Intravenous Lidocaine, Laparoscopic Surgery, Post Operative Recovery","enrollment":182},{"nctId":"NCT04245423","phase":"NA","title":"The Whole Health Study: Collaborative Care for OUD and Mental Health Conditions","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Pennsylvania","startDate":"2020-12-15","conditions":"Opioid-use Disorder, Mental Health Conditions","enrollment":567},{"nctId":"NCT04743661","phase":"PHASE2","title":"131I-Omburtamab, in Recurrent Medulloblastoma and Ependymoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Pediatric Brain Tumor Consortium","startDate":"2022-04-04","conditions":"Recurrent Medulloblastoma, Recurrent Ependymoma","enrollment":62},{"nctId":"NCT07388251","phase":"NA","title":"Effect of Intraperitoneal Dexmedetomidine Added to Bupivacaine 0.25% Versus Bupivacaine Alone on Postoperative Analgesia in Patients Undergoing Laparoscopic Cholecystectomy","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2025-03-02","conditions":"Postoperative Pain Management, Cholelithiasis, Laparoscopic Cholecystectomy","enrollment":30},{"nctId":"NCT07385742","phase":"NA","title":"Botulinum Toxin Versus Platelet Rich Fibrin for TMJ Internal Derangement","status":"COMPLETED","sponsor":"Suez Canal University","startDate":"2024-01-10","conditions":"Temporomandibular Joint Internal Derangement, Temporomandibular Joint Disorders, Temporomandibular Disorders (TMD)","enrollment":20},{"nctId":"NCT06411223","phase":"PHASE2","title":"Pharmacist-led Intervention for Injectable HIV Treatment for Women With Health-related Social Needs","status":"ACTIVE_NOT_RECRUITING","sponsor":"Yale University","startDate":"2024-08-01","conditions":"Hiv","enrollment":50},{"nctId":"NCT07214987","phase":"PHASE2","title":"PDT For Induction Therapy For Head And Neck Cancer","status":"NOT_YET_RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2026-03-09","conditions":"Squamous Cell Carcinoma, Head and Neck Cancer Squamous Cell Carcinoma, Head and Neck Cancer","enrollment":26},{"nctId":"NCT07377253","phase":"PHASE1","title":"First-in-Human Study Testing a New Antibody Treatment for Tick-Borne Encephalitis in Healthy Volunteers.","status":"NOT_YET_RECRUITING","sponsor":"Giuseppe Pantaleo","startDate":"2026-01-01","conditions":"The Tick-borne Encephalitis Virus (TBEV)","enrollment":18},{"nctId":"NCT03497676","phase":"PHASE1, PHASE2","title":"More Options for Children and Adolescents (MOCHA): Oral and Long-Acting Injectable Cabotegravir and Rilpivirine in HIV-Infected Children and Adolescents","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2019-04-03","conditions":"HIV Infections","enrollment":168},{"nctId":"NCT06910943","phase":"PHASE2, PHASE3","title":"Study of Choline Chloride for Injection in Adolescent and Adult Patients With Intestinal Failure Receiving Long Term Parenteral Support","status":"RECRUITING","sponsor":"Protara Therapeutics","startDate":"2025-12-10","conditions":"Choline Deficiency, Liver Injury","enrollment":129},{"nctId":"NCT03642626","phase":"PHASE2","title":"MT2017-45: CAR-T Cell Therapy for Heme Malignancies","status":"ACTIVE_NOT_RECRUITING","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2018-12-18","conditions":"Acute Lymphoblastic Leukemia, Large B-cell Lymphoma","enrollment":150},{"nctId":"NCT04995003","phase":"PHASE1","title":"HER2 Chimeric Antigen Receptor (CAR) T Cells in Combination With Checkpoint Blockade in Patients With Advanced Sarcoma","status":"RECRUITING","sponsor":"Baylor College of Medicine","startDate":"2021-12-07","conditions":"Sarcoma, HER-2 Protein Overexpression, Osteosarcoma","enrollment":25},{"nctId":"NCT05028062","phase":"PHASE4","title":"Naltrexone in AUD Reward Drinkers","status":"RECRUITING","sponsor":"University of Pennsylvania","startDate":"2022-03-07","conditions":"Alcohol Use Disorder, Alcoholism","enrollment":60},{"nctId":"NCT07344246","phase":"NA","title":"Efficacy and Safety of Intravenous Dexamethasone Palmitate Treatments in Acute and Subacute Herpes Zoster Pain","status":"NOT_YET_RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2026-02-01","conditions":"Herpes Zoster Pain","enrollment":954},{"nctId":"NCT03056755","phase":"PHASE2","title":"Study Assessing the Efficacy and Safety of Alpelisib Plus Fulvestrant or Letrozole, Based on Prior Endocrine Therapy, in Patients With PIK3CA Mutant, HR+, HER2- Advanced Breast Cancer Who Have Progressed on or After Prior Treatments","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2017-08-29","conditions":"Breast Cancer","enrollment":383},{"nctId":"NCT04375033","phase":"PHASE4","title":"A Study Comparing Oral Buprenorphine and Injectable Buprenorphine for the Treatment of Opioid Use Disorder","status":"RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2020-11-03","conditions":"Opioid Use Disorder","enrollment":952},{"nctId":"NCT07330063","phase":"PHASE2","title":"Efficacy and Safety of Anrikefon Injection for the Treatment of Postoperative Pain in Patients Undergoing Totally Laparoscopic Radical Distal Gastrectomy","status":"NOT_YET_RECRUITING","sponsor":"Tianjin Medical University Cancer Institute and Hospital","startDate":"2025-12-22","conditions":"Gastrectomy","enrollment":114},{"nctId":"NCT04002180","phase":"","title":"Specified Drug-Use Survey on Vedolizumab for IV Infusion 300 mg [Crohn's Disease]","status":"ACTIVE_NOT_RECRUITING","sponsor":"Takeda","startDate":"2019-07-01","conditions":"Crohn's Disease","enrollment":335},{"nctId":"NCT07322445","phase":"NA","title":"Multi-modal Imaging of Myofascial Pain - Phase 2","status":"RECRUITING","sponsor":"Washington University School of Medicine","startDate":"2025-10-01","conditions":"Myofascial Pain","enrollment":100},{"nctId":"NCT07314385","phase":"PHASE1","title":"NH002-mediated Sonoporation With Chemotherapy in Advanced Pancreatic Cancer","status":"NOT_YET_RECRUITING","sponsor":"National Taiwan University Hospital","startDate":"2026-01-01","conditions":"Pancreatic Adenocarcinoma Metastatic, Liver Metastasis","enrollment":24},{"nctId":"NCT06109948","phase":"EARLY_PHASE1","title":"Study to Assess the Safety, Tolerability, PK and PD of ABX1100","status":"ACTIVE_NOT_RECRUITING","sponsor":"Aro Biotherapeutics","startDate":"2023-10-19","conditions":"Healthy, Late Onset Pompe Disease","enrollment":46},{"nctId":"NCT02821169","phase":"PHASE3","title":"Infiltration in the Region of the Palatine Ganglion Spheno by Ropivacaine on Postoperative Pain","status":"COMPLETED","sponsor":"University Hospital, Lille","startDate":"2015-04","conditions":"Pain","enrollment":184},{"nctId":"NCT03638999","phase":"EARLY_PHASE1","title":"NSAIDs Stent Study","status":"RECRUITING","sponsor":"Washington University School of Medicine","startDate":"2018-07-31","conditions":"Ureteral Stent Placement, Kidney Stone","enrollment":36},{"nctId":"NCT03959761","phase":"PHASE1, PHASE2","title":"Tolerance of Intraperitoneal (IP) Nivolumab After Extensive Debulking Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Ovarian Carcinoma","status":"COMPLETED","sponsor":"Hospices Civils de Lyon","startDate":"2019-10-17","conditions":"Ovarian Cancer","enrollment":22},{"nctId":"NCT04222504","phase":"NA","title":"Community-based Venues for Delivery of Healthcare Services: Proof of Concept Pilot","status":"ACTIVE_NOT_RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2021-02-08","conditions":"Pre-Exposure Prophylaxis, STI, Contraceptive Usage","enrollment":500},{"nctId":"NCT03567889","phase":"PHASE3","title":"Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients","status":"RECRUITING","sponsor":"Philogen S.p.A.","startDate":"2018-09-20","conditions":"Melanoma Stage IIIB, Melanoma Stage IIIC, Melanoma Stage IIID","enrollment":186},{"nctId":"NCT07151638","phase":"NA","title":"First-in-Human Safety Study for Fractomer™ Biomatrix","status":"COMPLETED","sponsor":"inSoma Bio, Inc.","startDate":"2025-08-11","conditions":"Soft Tissue, Soft Tissue Defects, Subcutaneous Injection","enrollment":2},{"nctId":"NCT07286253","phase":"PHASE2","title":"QL1706 Plus Chemotherapy as Neoadjuvant Therapy for Locally Advanced Cervical Cancer: A Phase II Trial","status":"RECRUITING","sponsor":"Affiliated Cancer Hospital & Institute of Guangzhou Medical University","startDate":"2025-10-28","conditions":"Neoadjuvant Treatment for Locally Advanced Cervical Cancer","enrollment":50},{"nctId":"NCT04464980","phase":"PHASE2","title":"Optimizing Retention, Duration and Discontinuation Strategies for Opioid Use Disorder Pharmacotherapy (RDD)","status":"ACTIVE_NOT_RECRUITING","sponsor":"NYU Langone Health","startDate":"2021-06-08","conditions":"Opioid Use Disorder (OUD)","enrollment":1516},{"nctId":"NCT06630884","phase":"PHASE1","title":"Inflammatory Challenge and Fear","status":"RECRUITING","sponsor":"University of California, San Francisco","startDate":"2025-03-28","conditions":"Posttraumatic Stress Disorder (PTSD)","enrollment":288},{"nctId":"NCT07272590","phase":"PHASE1, PHASE2","title":"Study of QLC5513 in Combination With Epalolimab Tovolimab (QL1706) ± Platinum in Patients With Advanced or Metastatic Malignant Solid Tumors","status":"NOT_YET_RECRUITING","sponsor":"Qilu Pharmaceutical Co., Ltd.","startDate":"2025-12-30","conditions":"Metastatic Solid Tumors","enrollment":290},{"nctId":"NCT03378414","phase":"PHASE2","title":"Umbilical Cord Mesenchymal Stem Cells Therapy (19#iSCLife®-SA) for Patients With Spinocerebellar Ataxia","status":"NOT_YET_RECRUITING","sponsor":"Sclnow Biotechnology Co., Ltd.","startDate":"2025-12-31","conditions":"Spinocerebellar Ataxia Type 1, Spinocerebellar Ataxia Type 2, Spinocerebellar Ataxia Type 3","enrollment":45},{"nctId":"NCT06049680","phase":"PHASE4","title":"Safety Study of SMOFlipid to Evaluate the Risk of Developing EFAD and/or PNAC in Pediatric and Adult Patients","status":"RECRUITING","sponsor":"Fresenius Kabi","startDate":"2024-10-28","conditions":"Malnutrition, Child, Malnutrition, Essential Fatty Acid Deficiency (EFAD)","enrollment":100},{"nctId":"NCT04166877","phase":"PHASE4","title":"Magnesium Infusion for Pain Management in Critically Ill Trauma Patients","status":"RECRUITING","sponsor":"University of California, Davis","startDate":"2019-12-07","conditions":"Trauma, Acute Pain","enrollment":156},{"nctId":"NCT07243691","phase":"NA","title":"Study on the Therapeutic Effect of Different Infusion Times of Tislelizumab on Postoperative High-risk Hepatocellular Carcinoma","status":"RECRUITING","sponsor":"Sir Run Run Shaw Hospital","startDate":"2025-12-01","conditions":"Hepatocellular Carcinoma","enrollment":33},{"nctId":"NCT05631899","phase":"PHASE1","title":"CAR-DC Vaccine and ICIs in Local Advanced/Metastatic Solid Tumors","status":"ACTIVE_NOT_RECRUITING","sponsor":"Chinese PLA General Hospital","startDate":"2023-04-03","conditions":"Solid Tumor, Adult, EphA2 Overexpression, KRAS G12V","enrollment":9},{"nctId":"NCT07220382","phase":"PHASE4","title":"Preoperative BOTOX® Injection for Large Ventral Hernia Repair","status":"RECRUITING","sponsor":"The Cleveland Clinic","startDate":"2025-11-03","conditions":"Hernia Abdominal Wall, Botox Injection, Hernia Incisional Ventral","enrollment":188},{"nctId":"NCT07237711","phase":"NA","title":"Clinical Investigation of Sensovisc","status":"NOT_YET_RECRUITING","sponsor":"Ankara City Hospital Bilkent","startDate":"2025-11-25","conditions":"Osteo Arthritis of the Knee","enrollment":75},{"nctId":"NCT04214626","phase":"PHASE2","title":"R-CHOP Combined With Lenalidomide in the First-line Treatment for Patients With Diffuse Large B Cell Lymphoma","status":"COMPLETED","sponsor":"Henan Cancer Hospital","startDate":"2020-01-05","conditions":"Diffuse Large B Cell Lymphoma","enrollment":60},{"nctId":"NCT06078384","phase":"PHASE2","title":"Pembrolizumab and Chemotherapy Treatment or no Treatment Guided by the Level of TILs in Resected Early-stage TNBC","status":"RECRUITING","sponsor":"UNICANCER","startDate":"2024-12-27","conditions":"Triple-negative Breast Cancer","enrollment":354},{"nctId":"NCT03431064","phase":"","title":"Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients","status":"RECRUITING","sponsor":"Boston Children's Hospital","startDate":"2018-06-21","conditions":"Anesthesia, Intravenous Fluid, Blood Pressure","enrollment":48},{"nctId":"NCT03743194","phase":"PHASE4","title":"Pectoralis and Serratus Muscle Blocks","status":"COMPLETED","sponsor":"The Cleveland Clinic","startDate":"2021-12-14","conditions":"Post Operative Pain Control","enrollment":210},{"nctId":"NCT03805607","phase":"PHASE4","title":"IV Ketorolac on Platelet Function Post-Cesarean Delivery","status":"COMPLETED","sponsor":"Beth Israel Deaconess Medical Center","startDate":"2021-01-18","conditions":"Analgesia, Obstetrical, Coagulation Defect; Postpartum, Nonsteroidals (NSAIDs)Toxicity","enrollment":40},{"nctId":"NCT06449027","phase":"PHASE3","title":"Safety, Efficacy and Pharmacokinetic Behavior of Leuprolide Injectable Emulsion for Premenopausal Breast Cancer Subjects.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Changchun GeneScience Pharmaceutical Co., Ltd.","startDate":"2024-08-21","conditions":"Breast Cancer Subjects","enrollment":211},{"nctId":"NCT07194304","phase":"EARLY_PHASE1","title":"Effect of Parenteral Alpha-Tocopherol in the Definitive Surgery of Tetralogy of Fallot","status":"COMPLETED","sponsor":"Dr Cipto Mangunkusumo General Hospital","startDate":"2022-05-01","conditions":"Tetralogy of Fallot (TOF), Alpha-tocopherol, Cardiac Surgery","enrollment":60},{"nctId":"NCT07179003","phase":"PHASE2","title":"A Phase 2 Study of Methylene Blue Photodynamic Therapy for Treatment of Breast Abscesses","status":"NOT_YET_RECRUITING","sponsor":"University of Rochester","startDate":"2026-04","conditions":"Breast Abscess","enrollment":50},{"nctId":"NCT06452654","phase":"PHASE4","title":"Anti-viral Action Against Type 1 Diabetes Autoimmunity","status":"RECRUITING","sponsor":"Technical University of Munich","startDate":"2024-05-08","conditions":"Diabetes Mellitus, Type 1","enrollment":2252},{"nctId":"NCT07179328","phase":"PHASE1","title":"Focused Ultrasound Blood-Brain Barrier Disruption for the Treatment of High-Grade Glioma in Patients Undergoing Standard Chemotherapy","status":"RECRUITING","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2025-06-04","conditions":"GBM, Glioblastoma Multiforme (GBM), Glioblastoma Multiforme of Brain","enrollment":10},{"nctId":"NCT03824561","phase":"","title":"Special Drug-Use Surveillance Study on Vedolizumab for IV Infusion 300 mg [Ulcerative Colitis]","status":"COMPLETED","sponsor":"Takeda","startDate":"2019-02-01","conditions":"Ulcerative Colitis","enrollment":1110},{"nctId":"NCT04037605","phase":"EARLY_PHASE1","title":"Hormonal Mechanisms of Sleep Restriction - Axis Study in Older Men and Postmenopausal Women","status":"ACTIVE_NOT_RECRUITING","sponsor":"Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center","startDate":"2020-02-09","conditions":"Sleep Restriction","enrollment":5},{"nctId":"NCT03275506","phase":"PHASE2","title":"PEMBRO With Chemo in Neo Adj Treatment of Ovarian Cancer .","status":"COMPLETED","sponsor":"ARCAGY/ GINECO GROUP","startDate":"2018-02-26","conditions":"Ovarian Cancer Stage IV","enrollment":91},{"nctId":"NCT04908787","phase":"PHASE3","title":"A Phase III Study of BD0801 Combined With Chemotherapy in Recurrent, Platinum-resistant Epithelial Ovarian Cancer","status":"COMPLETED","sponsor":"Jiangsu Simcere Pharmaceutical Co., Ltd.","startDate":"2021-06-11","conditions":"Ovarian Cancer","enrollment":421},{"nctId":"NCT03142893","phase":"PHASE1","title":"Hormonal Mechanisms of Sleep Restriction - Axis Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"Peter y. Liu","startDate":"2017-05-08","conditions":"Sleep Restriction","enrollment":80},{"nctId":"NCT06895408","phase":"NA","title":"Separate and Combined Extrapancreatic Effects of GIP and GLP-1","status":"COMPLETED","sponsor":"University Hospital, Gentofte, Copenhagen","startDate":"2025-02-19","conditions":"Pancreatectomy; Hyperglycemia","enrollment":12},{"nctId":"NCT06434636","phase":"NA","title":"The Effect of Tranexamic Acid in Endoscopic and Microscopic Ear Surgery Cases on Surgeon Satisfaction","status":"COMPLETED","sponsor":"TC Erciyes University","startDate":"2024-12-01","conditions":"Middle Ear Disease","enrollment":100},{"nctId":"NCT06490718","phase":"NA","title":"Comparing Quality of Recovery Between ESPB and IV Lidocaine After Major Breast Cancer Surgery","status":"COMPLETED","sponsor":"Chinese University of Hong Kong","startDate":"2024-10-25","conditions":"Breast Neoplasms","enrollment":80},{"nctId":"NCT05938322","phase":"NA","title":"Ketogenic Diet Compliance in Patients Undergoing Radiotherapy for Pelvic Cancers","status":"RECRUITING","sponsor":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","startDate":"2024-06-10","conditions":"Rectal Cancer","enrollment":194},{"nctId":"NCT04099797","phase":"PHASE1","title":"C7R-GD2.CAR T Cells for Patients With GD2-expressing Brain Tumors (GAIL-B)","status":"RECRUITING","sponsor":"Baylor College of Medicine","startDate":"2020-02-03","conditions":"Diffuse Intrinsic Pontine Glioma, High Grade Glioma, Embryonal Tumor","enrollment":37},{"nctId":"NCT06505837","phase":"PHASE3","title":"JS001sc or JS001 Plus Chemotherapy is Indicated for Relapsed or Metastatic First-Line Non-Squamous Non Small Cell Lung Cancer（NSCLC）","status":"ACTIVE_NOT_RECRUITING","sponsor":"Shanghai Junshi Bioscience Co., Ltd.","startDate":"2024-07-11","conditions":"Recurrent Metastatic Non-Squamous Non Small Cell Lung Cancer","enrollment":395},{"nctId":"NCT03850574","phase":"PHASE1, PHASE2","title":"Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia","status":"RECRUITING","sponsor":"Aptose Biosciences Inc.","startDate":"2019-03-11","conditions":"Leukemia, Myeloid, Acute, Refractory AML, Relapsed Adult AML","enrollment":240},{"nctId":"NCT03405870","phase":"PHASE1, PHASE2","title":"LIPIDS-P Trial Phase I/II Trial","status":"COMPLETED","sponsor":"University of Florida","startDate":"2018-08-17","conditions":"Sepsis, Severe, Septic Shock","enrollment":59},{"nctId":"NCT04454411","phase":"PHASE2","title":"Brain Mechanisms of Pharmacotherapy in Opioid Use Disorder","status":"TERMINATED","sponsor":"University of Pennsylvania","startDate":"2022-08-01","conditions":"Opioid Dependence","enrollment":3},{"nctId":"NCT05894889","phase":"PHASE2","title":"Pembrolizumab and Chemotherapy Neoadjuvant/Adjuvant of NSCLC","status":"ACTIVE_NOT_RECRUITING","sponsor":"Peking University","startDate":"2024-01-30","conditions":"Stage IIIB(N2) Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer","enrollment":70},{"nctId":"NCT06367075","phase":"PHASE2","title":"A Trial of Cadonilimab With Adriamycin in Patients With Advanced Soft Tissue Sarcoma","status":"RECRUITING","sponsor":"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","startDate":"2024-10-09","conditions":"Advanced Soft-tissue Sarcoma","enrollment":53},{"nctId":"NCT06973304","phase":"PHASE3","title":"A Study of Teduglutide in Chinese Adults With Short Bowel Syndrome","status":"RECRUITING","sponsor":"Takeda","startDate":"2025-06-26","conditions":"Short Bowel Syndrome","enrollment":13},{"nctId":"NCT07045701","phase":"PHASE2, PHASE3","title":"FMXIN002 in Patients at Risk of Anaphylaxis","status":"ENROLLING_BY_INVITATION","sponsor":"Nasus Pharma","startDate":"2025-06-12","conditions":"Anaphylaxis Food","enrollment":30},{"nctId":"NCT06833931","phase":"PHASE2","title":"A Study of PGN-EDO51 or Placebo in People With Duchenne Muscular Dystrophy Amenable to Exon 51-Skipping Treatment","status":"WITHDRAWN","sponsor":"PepGen Inc","startDate":"2024-12-17","conditions":"Duchenne Muscular Dystrophy (DMD)","enrollment":""},{"nctId":"NCT07024030","phase":"PHASE2","title":"Safety and Efficacy Trial of a Targeted PSMA Fluorescent Contrast Agent (DGPR1008) for Intraoperative Imaging of Prostate Cancer","status":"COMPLETED","sponsor":"Haitao Niu, MD","startDate":"2024-10-30","conditions":"Prostate Cancer Patients Undergoing Radical Prostatectomy","enrollment":24},{"nctId":"NCT05065372","phase":"PHASE1","title":"MANATEE-T1D: Metformin ANd AutomaTEd Insulin Delivery System Effects on Renal Vascular Resistance, Insulin Sensitivity, and Cardiometabolic Function in Youth With Type 1 Diabetes","status":"RECRUITING","sponsor":"Kalie Tommerdahl","startDate":"2022-07-01","conditions":"Type 1 Diabetes, Diabetic Kidney Disease, Cardiovascular Diseases","enrollment":60},{"nctId":"NCT07007351","phase":"NA","title":"Multicenter, Prospective Study to Determine the Performance and Safety of the New M-HA30 Architect Device on the Quality of the Skin: HEBE8 Study","status":"COMPLETED","sponsor":"Laboratoires FILLMED","startDate":"2023-03-19","conditions":"Skin Aging","enrollment":285},{"nctId":"NCT01696565","phase":"PHASE1, PHASE2","title":"PG2 Phase I/II Clinical Study Intravenously Administered in Patients With Advanced Malignancy","status":"COMPLETED","sponsor":"PhytoHealth Corporation","startDate":"2001-12","conditions":"Neoplasm Metastasis, Neoplasm Recurrence","enrollment":32},{"nctId":"NCT06993558","phase":"NA","title":"Analysis of Safety and Tissue Interaction of Injectable and Energy-based Biosmulators","status":"RECRUITING","sponsor":"Universitätsklinikum Hamburg-Eppendorf","startDate":"2025-03-22","conditions":"This Study Aims to Evaluate the Safety Profile and Tissue Changes After Biostimulatory Treatments to the Face in Healthy Volunteers","enrollment":90},{"nctId":"NCT05222204","phase":"PHASE2","title":"DDP ip Combined With AG in PDAC With Peritoneal Metastasis","status":"COMPLETED","sponsor":"Fudan University","startDate":"2022-05-15","conditions":"Pancreatic Neoplasm","enrollment":91},{"nctId":"NCT01125449","phase":"PHASE2","title":"Study of High Dose Intravenous (IV) Ascorbic Acid in Measurable Solid Tumor Disease","status":"WITHDRAWN","sponsor":"Situs Cancer Research Center","startDate":"2020-01-01","conditions":"Sarcoma, Adenocarcinoma, Carcinoma","enrollment":""},{"nctId":"NCT03949907","phase":"NA","title":"Early IntraVenous Administration of Nutritional Support","status":"TERMINATED","sponsor":"Fondazione IRCCS Policlinico San Matteo di Pavia","startDate":"2020-04-14","conditions":"Cancer of Stomach, GastroEsophageal Cancer","enrollment":34},{"nctId":"NCT04737889","phase":"PHASE2","title":"Rituximab, Lenalidomide Combined With Methotrexate and Temozolomide For Primary Central Nervous System Lymphoma","status":"RECRUITING","sponsor":"Henan Cancer Hospital","startDate":"2021-01-13","conditions":"Primary Central Nervous System Lymphoma","enrollment":30},{"nctId":"NCT04064294","phase":"","title":"Preventing Levodopa Induced Dyskinesia in Parkinson's Disease With HMG-CoA Reductase Inhibitors","status":"COMPLETED","sponsor":"VA Office of Research and Development","startDate":"2019-08-22","conditions":"Parkinson Disease, Dyskinesia, Drug-Induced","enrollment":93},{"nctId":"NCT06920810","phase":"PHASE4","title":"Viscum Album for TNBC on Adjuvant Pembrolizumab","status":"RECRUITING","sponsor":"Ilsan Cha hospital","startDate":"2025-03-19","conditions":"Breast Cancer, Triple Negative Breast Cancer","enrollment":40},{"nctId":"NCT03903835","phase":"PHASE3","title":"ProBio: A Biomarker Driven Study in Patients With Metastatic Prostate Cancer","status":"RECRUITING","sponsor":"Karolinska Institutet","startDate":"2019-02-01","conditions":"Metastatic Castration-resistant Prostate Cancer (mCRPC), Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)","enrollment":750},{"nctId":"NCT06916585","phase":"PHASE2","title":"Chinese Phase II Trail of AS1501 in Acute-on-chronic Liver Failure (ACLF) Patients","status":"NOT_YET_RECRUITING","sponsor":"Shenzhen Third People's Hospital","startDate":"2025-04-15","conditions":"Acute-On-Chronic Liver Failure","enrollment":96},{"nctId":"NCT06200168","phase":"PHASE3","title":"Electroacupuncture for the Prevention of Chemotherapy-induced Nausea and Vomiting in Patients With Breast Cancer","status":"RECRUITING","sponsor":"Jiuda Zhao","startDate":"2024-01-16","conditions":"Electroacupuncture, Olanzapine-contained Four-drug Antiemetic, Nausea and Vomiting","enrollment":370},{"nctId":"NCT03290196","phase":"PHASE4","title":"The Effect of EXPAREL® on Postsurgical Pain, and the Use of Narcotics","status":"TERMINATED","sponsor":"Andrews Research & Education Foundation","startDate":"2015-09-03","conditions":"Rotator Cuff Tear","enrollment":13},{"nctId":"NCT06288360","phase":"PHASE2","title":"Neoadjuvant Immunochemotherapy in PD-L1-negative LACC","status":"RECRUITING","sponsor":"Tongji Hospital","startDate":"2024-09-12","conditions":"Cervical Cancer, Locally Advanced Cervical Cancer, PD-L1 Negative","enrollment":40},{"nctId":"NCT06883201","phase":"","title":"Application of Patient Blood Management in the Oncology Patient Affected by Breast Cancer","status":"RECRUITING","sponsor":"Regina Elena Cancer Institute","startDate":"2023-01-31","conditions":"Breast Cancer","enrollment":78},{"nctId":"NCT06876701","phase":"EARLY_PHASE1","title":"The Treatment of Newly Diagnosed CD19+Mixed Phenotype Acute Leukemia in Adults","status":"NOT_YET_RECRUITING","sponsor":"Ruijin Hospital","startDate":"2025-04-01","conditions":"Acute Leukemia","enrollment":10},{"nctId":"NCT04905446","phase":"NA","title":"Measurement of NAD+ Synthesis in Human Skeletal Muscle","status":"COMPLETED","sponsor":"AdventHealth Translational Research Institute","startDate":"2021-09-10","conditions":"Skeletal Muscle","enrollment":15},{"nctId":"NCT05350930","phase":"","title":"Multidisciplinary Care Program to Secure MEdication Therapy for HematoLOgy Patients Receiving Injectable Anticancer Drugs","status":"COMPLETED","sponsor":"Hospices Civils de Lyon","startDate":"2022-06-09","conditions":"Chemotherapy Effect, G-CHOP Chemotherapy, R-CHOP Chemotherapy","enrollment":38}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"parenteral chemotherapy","genericName":"parenteral chemotherapy","companyName":"Warwick Medical School","companyId":"warwick-medical-school","modality":"Small molecule","firstApprovalDate":"","aiSummary":"This drug targets cancer cells by inhibiting cell division and inducing apoptosis. Used for Treatment of various cancers.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}